New injection could ease pain after knee replacement
NCT ID NCT07191964
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study tests whether adding a simple numbing injection (SSSI) to standard pain blocks can better control pain after knee replacement surgery. About 90 adults aged 45-90 will be randomly assigned to receive either the extra injection or a sham (fake) one. The main goal is to see if the extra injection lowers pain scores on the day of surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 90 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 45-90 undergoing unilateral primary TKA for osteoarthritis. * American Society of Anesthesiologists (ASA) physical status I-III. * Able to provide informed consent and use NRS pain scales. * Surgery scheduled to start before noon to standardize spinal anesthesia recovery. Exclusion Criteria: * Bilateral or revision TKA. * Contraindications to regional anesthesia (e.g., coagulopathy, infection at injection site). * Chronic opioid use (\>30 mg morphine equivalents/day) or preoperative NRS \>4. * Pre-existing neurological deficits in lower extremities or AFCN-related neuropathy. * Allergy to ropivacaine. * Pregnancy, breastfeeding, or cognitive impairment affecting assessments.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Osteoarthritis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Taipei Municipal Wanfang Hospital
Taipei, 116, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a robot make a new knee feel like your own?
- Custom knee guides put to the test in obese patients
- Surgeons test augmented reality to Fine-Tune knee replacement cuts
- Can a purified form of ibuprofen better tame osteoarthritis pain?
- Could simple home exercises be the key to better knee health?
- Can a new plastic hip liner outlast the old ones?